BOLOGNESI ed altri: "Nuova disciplina delle attività trasfusionali e della produzione nazionale degli emoderivati" (143)

This procedure proposes new regulations for blood transfusion activities and the national production of blood-derived medicinal products. It aims to update and harmonize current practices to ensure safety and efficacy. The changes will affect blood banks, healthcare providers involved in transfusions, and companies producing blood-derived products. Patients receiving transfusions or treatments with these products will also be impacted by updated safety standards.